Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EVER Neuro Pharma is a specialist pharmaceutical company headquartered in Austria, focusing on the development and commercialization of therapies for neurological disorders and intensive care. The company is best known for its flagship product, Cerebrolysin, a multi-modal neuropeptide preparation used globally for the treatment of stroke, traumatic brain injury, and dementia. EVER Neuro Pharma operates a significant regional hub in Asia, managed through its Singapore-based subsidiary, to oversee clinical development and commercial operations across the Asia-Pacific region. The company maintains a strong focus on evidence-based medicine, supporting extensive clinical trial programs to validate its neuroprotective and neuroregenerative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EVER Neuro Pharma Asia.